Drugs / Sandimmun Neoral
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00138970 | Jan 2002 → Feb 2005 | disease related to solid organ transplantation | University of Oslo School of Pharmacy | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sandimmun Neoral | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00138970 ↗ |